Fiche personne
Territoire
Bourgogne
Statut
Hospitalo-Universitaire
Équipes/plateformes
Publications
Inhibition of LXR Signaling in Human Foam Cells Impairs Macrophage-to-Endothelial Cell Cross Talk and Promotes Endothelial Cell Inflammation.
Leleu D, Pilot T, Mangin L, Van Dongen K, Proukhnitzky L, Denimal D, Samson M, Laubriet A, Steinmetz E, Rialland M, Pierre L, Groetz E, Pais de Barros JP, Gautier T, Thomas C, Masson D
Arterioscler Thromb Vasc Biol. 2025 04 10;:
Macrophage caspase-8 inhibition accelerates necrotic core expansion in atheroma plaque in mice.
Pilot T, Solier S, Jalil A, Magnani C, Vanden Berghe T, Vandenabeele P, Masson D, Solary E, Thomas C
Front Immunol. 2025 04 8;16:1513637
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression.
Vouilloz A, Bourgeois T, Diedisheim M, Pilot T, Jalil A, Le Guern N, Bergas V, Rohmer N, Castelli F, Leleu D, Varin A, de Barros JP, Degrace P, Rialland M, Blériot C, Venteclef N, Thomas C, Masson D
Metabolism. 2024 10 23;:156051
Glucose metabolism controls monocyte homeostasis and migration but has no impact on atherosclerosis development in mice.
Gallerand A, Dolfi B, Stunault MI, Caillot Z, Castiglione A, Strazzulla A, Chen C, Heo GS, Luehmann H, Batoul F, Vaillant N, Dumont A, Pilot T, Merlin J, Zair FN, Gilleron J, Bertola A, Carmeliet P, Williams JW, Arguello RJ, Masson D, Dombrowicz D, Yvan-Charvet L, Doyen D, Haschemi A, Liu Y, Guinamard RR, Ivanov S
Nat Commun. 2024 10 19;15(1):9027
Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction.
Nguyen M, Putot A, Masson D, Cottin Y, Gautier T, Tribouillard L, Rérole AL, Guinot PG, Maza M, Pais de Barros JP, Deckert V, Farnier M, Lagrost L, Zeller M
Front Cardiovasc Med. 2024 06 25;11:1419001
A novel fatty acid analogue triggers CD36-GPR120 interaction and exerts anti-inflammatory action in endotoxemia.
Boutanquoi PM, Khan AS, Cabeza L, Jantzen L, Gautier T, Yesylevskyy S, Ramseyer C, Masson D, Van Waes V, Hichami A, Khan NA
Cell Mol Life Sci. 2024 04 10;81(1):176
Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction.
Masson D, Leleu D, Farnier M, Chagué F, Rampon C, Bichat F, Demeule C, Maza M, Pais de Barros JP, Cottin Y, Zeller M
Cardiovasc Res. 2024 01 9;:
Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis.
Ménégaut L, Laubriet A, Crespy V, Leleu D, Pilot T, Van Dongen K, de Barros JP, Gautier T, Petit JM, Thomas C, Nguyen M, Steinmetz E, Masson D
Cardiovasc Diabetol. 2023 09 14;22(1):248
Pneumococcal pneumonia and endotoxemia: An experimental and clinical reappraisal.
Godon J, Charles PE, Nguyen S, de Barros JP, Choubley H, Jacquier M, Tetu J, Quenot JP, Luu M, Binquet C, Masson D, Piroth L, Blot M,
Eur J Clin Invest. 2023 08 29;:e14077
Risk factors for kyphosis recurrence after implant removal in percutaneous osteosynthesis for post-traumatic thoracolumbar fracture.
Lainé G, Mezjan I, Masson D, Civit T, Mansouri N
Eur Spine J. 2023 08 22;:
Endotoxemia in Acute Heart Failure and Cardiogenic Shock: Evidence, Mechanisms and Therapeutic Options.
Nguyen M, Gautier T, Masson D, Bouhemad B, Guinot PG
J Clin Med. 2023 03 29;12(7):
Leukocyte cell population data in patients with cardiac surgery and cardiopulmonary bypass: A potential readily available tool to monitor immunity.
Nguyen M, Stiel L, Guilloteau A, Bahr PA, Masson D, Thomas C, Blot M, Guy J, Fontaine C, Durand B, Bouhemad B, Guinot PG
Front Immunol. 2023 01 19;13:1101937
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.
Rouland A, Masson D, Lagrost L, Vergès B, Gautier T, Bouillet B
Cardiovasc Diabetol. 2022 12 5;21(1):272
Increased Weight Gain and Insulin Resistance in HF-Fed PLTP Deficient Mice Is Related to Altered Inflammatory Response and Plasma Transport of Gut-Derived LPS.
Lebrun LJ, Pallot G, Nguyen M, Tavernier A, Dusuel A, Pilot T, Deckert V, Dugail I, Le Guern N, Pais De Barros JP, Benkhaled A, Choubley H, Lagrost L, Masson D, Gautier T, Grober J
Int J Mol Sci. 2022 10 30;23(21):
Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors.
Kieu TL, Pierre L, Derangère V, Perrey S, Truntzer C, Jalil A, Causse S, Groetz E, Dumont A, Guyard L, Arnould L, de Barros JP, Apetoh L, Rébé C, Limagne E, Jourdan T, Demizieux L, Masson D, Thomas C, Ghiringhelli F, Rialland M
Cell Death Dis. 2022 09 2;13(9):758
Profiling of lipid mediators in atherosclerotic carotid plaques from type 2 diabetic and non-diabetic patients.
Ménégaut L, Laubriet A, Crespy V, Nguyen M, Petit JM, Tarris G, Pilot T, Varin A, Choubley H, Bergas V, de Barros JP, Thomas C, Steinmetz E, Masson D
Prostaglandins Leukot Essent Fatty Acids. 2022 08 4;184:102477
High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for acute myocardial infarction. Data from the French RICO survey.
Farnier M, Chagué F, Maza M, Bichat F, Masson D, Cottin Y, Zeller M
J Clin Lipidol. 2022 07 17;:
The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid-remodeling enzyme, in health and disease.
Lagrost L, Masson D
Curr Opin Lipidol. 2022 Feb 14;:
Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.
Thomas C, Leleu D, Masson D
Front Immunol. 2022 ;13:868958
New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis.
Gautier T, Deckert V, Nguyen M, Desrumaux C, Masson D, Lagrost L
Pharmacol Ther. 2021 Dec 30;:108105
Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity.
Di Conza G, Tsai CH, Gallart-Ayala H, Yu YR, Franco F, Zaffalon L, Xie X, Li X, Xiao Z, Raines LN, Falquet M, Jalil A, Locasale JW, Percipalle P, Masson D, Huang SC, Martinon F, Ivanisevic J, Ho PC
Nat Immunol. 2021 Oct 22;:
Brown adipose tissue monocytes support tissue expansion.
Gallerand A, Stunault MI, Merlin J, Luehmann HP, Sultan DH, Firulyova MM, Magnone V, Khedher N, Jalil A, Dolfi B, Castiglione A, Dumont A, Ayrault M, Vaillant N, Gilleron J, Barbry P, Dombrowicz D, Mack M, Masson D, Bertero T, Becher B, Williams JW, Zaitsev K, Liu Y, Guinamard RR, Yvan-Charvet L, Ivanov S
Nat Commun. 2021 09 6;12(1):5255
Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice.
Gaillard D, Masson D, Garo E, Souidi M, Pais de Barros JP, Schoonjans K, Grober J, Besnard P, Thomas C
Int J Mol Sci. 2021 Jul 2;22(13):
Are adipokines the missing link between obesity, immune response, and outcomes in severe COVID-19?
Blot M, David Masson,Nguyen M, Bourredjem A, ,Binquet C, Piroth L
Int J Obes (Lond). 2021 May 31;:
High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia.
Nguyen M, Bourredjem A, Piroth L, Bouhemad B, Jalil A, Pallot G, Le Guern N, Thomas C, Pilot T, Bergas V, Choubley H, Quenot JP, Charles PE, Lagrost L, Deckert V, de Barros JP, Guinot PG, Masson D, Binquet C, Gautier T, Blot M,
Sci Rep. 2021 05 24;11(1):10824
Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
Farnier M, Zeller M, Masson D, Cottin Y
Arch Cardiovasc Dis. 2021 Feb 2;:
Human apolipoprotein C1 transgenesis reduces atherogenesis in hypercholesterolemic rabbits.
Gautier T, Deckert V, Aires V, Le Guern N, Proukhnitzky L, Patoli D, Lemaire S, Maquart G, Bataille A, Xolin M, Magnani C, Masson D, Harscoët E, Da Silva B, Houdebine LM, Jolivet G, Lagrost L
Atherosclerosis. 2021 Jan 12;320:10-18
Increased Phospholipid Transfer Protein Activity Is Associated With Markers of Enhanced Lipopolysaccharide Clearance in Human During Cardiopulmonary Bypass.
Nguyen M, Gautier T, Reocreux G, Pallot G, Maquart G, Bahr PA, Tavernier A, Grober J, Masson D, Bouhemad B, Guinot PG
Front Cardiovasc Med. 2021 ;8:756269
Intra-Abdominal Lipopolysaccharide Clearance and Inactivation in Peritonitis: Key Roles for Lipoproteins and the Phospholipid Transfer Protein.
Nguyen M, Pallot G, Jalil A, Tavernier A, Dusuel A, Le Guern N, Lagrost L, Pais de Barros JP, Choubley H, Bergas V, Guinot PG, Masson D, Bouhemad B, Gautier T
Front Immunol. 2021 ;12:622935
Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet.
Bourgeois T, Jalil A, Thomas C, Magnani C, Le Guern N, Gautier T, Pais de Barros JP, Bergas V, Choubley H, Mazzeo L, Menegaut L, Josiane Lebrun L, Van Dongen K, Xolin M, Jourdan T, Buch C, Labbé J, Saas P, Lagrost L, Masson D, Grober J
J Lipid Res. 2020 Dec 17;62:100013
Deletion of lysophosphatidylcholine acyltransferase3 in myeloid cells worsens hepatic steatosis after a high fat diet.
Bourgeois T, Jalil A, Thomas C, Magnani C, Le Guern N, Gautier T, Pais DE Barros JP, Bergas V, Choubley H, Mazzeo L, Menegaut L, Lebrun L, Van Dongen K, Xolin M, Jourdan T, Buch C, Labbé J, Saas P, Lagrost L, Masson D, Grober J
J Lipid Res. 2020 Dec 11;:
LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients.
Dargent A, Pais de Barros JP, Saheb S, Bittar R, Le Goff W, Carrié A, Gautier T, Fournel I, Rerole AL, Choubley H, Masson D, Lagrost L, Quenot JP
J Lipid Res. 2020 Dec;61(12):1776-1783
LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients.
Dargent A, Pais de Barros JP, Saheb S, Bittar R, Le Goff W, Carrié A, Gautier T, Fournel I, Rerole AL, Choubley H, Masson D, Lagrost L, Quenot JP
J Lipid Res. 2020 Dec;61(12):1776-1783
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS.
Blot M, Jacquier M, Aho Glele LS, Beltramo G, Nguyen M, Bonniaud P, Prin S, Andreu P, Bouhemad B, Bour JB, Binquet C, Piroth L, Pais de Barros JP, Masson D, Quenot JP, Charles PE,
Crit Care. 2020 11 2;24(1):632
LDL-apheresis as an alternate method for plasma LPS purification in healthy volunteers, dyslipidemic and septic patients.
Dargent A, Pais DE Barros JP, Saheb S, Bittar R, Le Goff W, Carrié A, Gautier T, Fournel I, Rérole AL, Choubley H, Masson D, Lagrost L, Quenot JP
J Lipid Res. 2020 Oct 9;:
Inhibition of mitophagy drives macrophage activation and anti-bacterial defense during sepsis.
Patoli D, Mignotte F, Deckert V, Dusuel A, Dumont A, Rieu A, Jalil A, Van Dongen K, Bourgeois T, Gautier T, Magnani C, Le Guern N, Mandard S, Bastin J, Djouadi F, Schaeffer C, Guillaumot N, Narce M, Nguyen M, Guy J, Dargent A, Quenot JP, Rialland M, Masson D, Auwerx J, Lagrost L, Thomas C
J. Clin. Invest.. 2020 Aug 6;:
Glucocorticoids impair HDL-mediated cholesterol efflux besides increased HDL cholesterol concentration - a proof of concept.
Bouillet B, Gautier T, Denimal D, Samson M, Masson D, Pais de Barros JP, Maquart G, Xolin M, Grosfeld A, Dalle H, Vergès B, Moldes M, Fève B
Eur. J. Endocrinol.. 2020 Jun 1;:
Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages.
Ménégaut L, Thomas C, Jalil A, Julla JB, Magnani C, Ceroi A, Basmaciyan L, Dumont A, Le Goff W, Mathew MJ, Rébé C, Dérangère V, Laubriet A, Crespy V, Pais de Barros JP, Steinmetz E, Venteclef N, Saas P, Lagrost L, Masson D
Cell Rep. 2020 May 19;31(7):107665
Fatty acids getting NAD+ about cardiometabolic diseases.
Jalil A, Thomas C, Masson D
Curr. Opin. Lipidol.. 2019 Dec;30(6):486-487
Macrophage fatty acid metabolism and atherosclerosis: The rise of PUFAs.
Ménégaut L, Jalil A, Thomas C, Masson D
Atherosclerosis. 2019 Oct 10;291:52-61
Improved quantification of plasma lipopolysaccharide (LPS) burden in sepsis using 3-hydroxy myristate (3HM): a cohort study.
Dargent A, Pais De Barros JP, Ksiazek E, Fournel I, Dusuel A, Rerole AL, Choubley H, Masson D, Lagrost L, Quenot JP
Intensive Care Med. 2019 Aug 26;:
Revisiting the Role of LXRs in PUFA Metabolism and Phospholipid Homeostasis.
Jalil A, Bourgeois T, Ménégaut L, Lagrost L, Thomas C, Masson D
Int J Mol Sci. 2019 Aug 2;20(15):
Healthy adiposity and extended lifespan in obese mice fed a diet supplemented with a polyphenol-rich plant extract.
Aires V, Labbé J, Deckert V, Pais de Barros JP, Boidot R, Haumont M, Maquart G, Le Guern N, Masson D, Prost-Camus E, Prost M, Lagrost L
Sci Rep. 2019 Jun 24;9(1):9134
End-Stage Renal Disease-Associated Gut Bacterial Translocation: Evolution and Impact on Chronic Inflammation and Acute Rejection After Renal Transplantation.
Carron C, Pais de Barros JP, Gaiffe E, Deckert V, Adda-Rezig H, Roubiou C, Laheurte C, Masson D, Simula-Faivre D, Louvat P, Moulin B, Frimat L, Rieu P, Mousson C, Durrbach A, Heng AE, Saas P, Ducloux D, Lagrost L, Bamoulid J
Front Immunol. 2019 ;10:1630
Polysaccharide Chain Length of Lipopolysaccharides From Minnesota Is a Determinant of Aggregate Stability, Plasma Residence Time and Proinflammatory Propensity .
Sali W, Patoli D, Pais de Barros JP, Labbé J, Deckert V, Duhéron V, Le Guern N, Blache D, Chaumont D, Lesniewska E, Gasquet B, Paul C, Moreau M, Denat F, Masson D, Lagrost L, Gautier T
Front Microbiol. 2019 ;10:1774
Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways.
Hu Y, Semova I, Sun X, Kang H, Chahar S, Hollenberg AN, Masson D, Hirschey MD, Miao J, Biddinger SB
J. Biol. Chem.. 2018 Feb 9;293(6):2006-2014
Fatty acids and macrophage functions: an update.
Thomas C, Ménégaut L, Masson D
Curr. Opin. Lipidol.. 2017 Oct;28(5):443-444
Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis.
Deckert V, Lemaire S, Ripoll PJ, de Barros JP, Labbé J, Borgne CC, Turquois V, Maquart G, Larose D, Desroche N, Ménétrier F, Le Guern N, Lebrun LJ, Desrumaux C, Gautier T, Grober J, Thomas C, Masson D, Houdebine LM, Lagrost L
Sci Rep. 2017 Jun;7(1):3053
[Liver X receptors as targets in inflammatory or leukemic plasmacytoid dendritic cells].
Ceroi A, Masson D, Garnache-Ottou F, Saas P
Med Sci (Paris). 2017 Mar;33(3):345-348
Fatty acid metabolism in macrophages: a target in cardio-metabolic diseases.
Ménégaut L, Thomas C, Lagrost L, Masson D
Curr. Opin. Lipidol.. 2017 Feb;28(1):19-26
LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
Ceroi A, Masson D, Roggy A, Roumier C, Chagué C, Gauthier T, Philippe L, Lamarthée B, Angelot-Delettre F, Bonnefoy F, Perruche S, Biichle S, Preudhomme C, Macintyre E, Lagrost L, Garnache-Ottou F, Saas P
Blood. 2016 Dec;128(23):2694-2707
Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
Ménégaut L, Masson D, Abello N, Denimal D, Truntzer C, Ducoroy P, Lagrost L, Pais de Barros JP, Athias A, Petit JM, Martin L, Steinmetz E, Kretz B
Atherosclerosis. 2016 Aug;251:339-47
The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation.
Ceroi A, Delettre FA, Marotel C, Gauthier T, Asgarova A, Biichlé S, Duperrier A, Mourey G, Perruche S, Lagrost L, Masson D, Saas P
Haematologica. 2016 Mar;101(3):e72-6
Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.
Sun X, Haas ME, Miao J, Mehta A, Graham MJ, Crooke RM, Pais de Barros JP, Wang JG, Aikawa M, Masson D, Biddinger SB
J. Biol. Chem.. 2016 Jan 15;291(3):1115-22
Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.
Denimal D, Ménégaut L, Rossi C, Duvillard L, Masson D
Biochem Med (Zagreb). 2016 ;26(2):255-9
The potential of cholesteryl ester transfer protein as a therapeutic target.
Gautier T, Masson D, Lagrost L
Expert Opin. Ther. Targets. 2016 ;20(1):47-59
Diagnostic Accuracy of Inflammatory Markers As Early Predictors of Infection After Elective Colorectal Surgery: Results From the IMACORS Study.
Facy O, Paquette B, Orry D, Binquet C, Masson D, Bouvier A, Fournel I, Charles PE, Rat P, Ortega-Deballon P
Ann Surg. 2015 Jul 1.
Are Adiponectin and Leptin Good Predictors of Surgical Infection after Colorectal Surgery? A Prospective Study.
Ortega-Deballon P, Menegaut L, Fournel I, Orry D, Masson D, Binquet C, Facy O
Surg Infect (Larchmt). 2015 Jun 26.
Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression.
Chalmin F, Mignot G, Bruchard M, Chevriaux A, Vegran F, Hichami A, Ladoire S, Derangere V, Vincent J, Masson D, Robson SC, Eberl G, Pallandre JR, Borg C, Ryffel B, Apetoh L, Rebe C, Ghiringhelli F
Immunity. 2012 Mar 23;36(3):362-73
